FDA Approves Medtronic's Leadless Pacemaker With Large Postmarket Trial Condition

FDA approved Medtronic’s Micra transcatheter leadless single-chamber pacemaker, beating out St. Jude’s Nanostim to be the first transcatheter leadless pacemaker to earn FDA approval.

The April 6 PMA approval is based primarily on the results of a 725-patient trial